ICOS has been found to be highly expressed on activated CD4+ T cells in patients with autoimmune conditions such as rheumatoid arthritis (RA), SLE, and inflammatory bowel disease [11–13]. This evidence concerns the gene CD4 and rheumatoid arthritis.